Literature DB >> 31404223

Dexmedetomidine to Treat 3, 4-Methylenedioxymethamphetamine-Induced Agitation in a 13-Month-Old Infant: A Case Report and Literature Review.

Patricia J L T Sanders1, Jan Hanot1.   

Abstract

We report a 13-month-old infant who accidentally ingested a tablet of 3, 4-methylenedioxymethamphetamine (MDMA) and was brought to the emergency department with tachycardia, seizures, mydriasis, and altered mental status. The patient received multiple doses of benzodiazepines to treat the seizures and developed respiratory insufficiency needing intubation. After extubation, the patient developed hyperactivity, myoclonic, and choreoathetoid movements which were unresponsive to benzodiazepines. Dexmedetomidine was started with good response. The patient made a full clinical recovery. This is the first case that illustrates the possibility to treat MDMA-induced agitation with dexmedetomidine in a 13-month-old infant.

Entities:  

Keywords:  MDMA; dexmedetomidine; infant

Year:  2019        PMID: 31404223      PMCID: PMC6687446          DOI: 10.1055/s-0039-1677815

Source DB:  PubMed          Journal:  J Pediatr Intensive Care        ISSN: 2146-4626


  13 in total

Review 1.  Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review.

Authors:  John R Richards; Timothy E Albertson; Robert W Derlet; Richard A Lange; Kent R Olson; B Zane Horowitz
Journal:  Drug Alcohol Depend       Date:  2015-02-18       Impact factor: 4.492

2.  Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers.

Authors:  Cédric M Hysek; Robin Brugger; Linda D Simmler; Marcel Bruggisser; Massimiliano Donzelli; Eric Grouzmann; Marius C Hoener; Matthias E Liechti
Journal:  J Pharmacol Exp Ther       Date:  2011-10-27       Impact factor: 4.030

Review 3.  Dexmedetomidine for opioid and benzodiazepine withdrawal in pediatric patients.

Authors:  Alexandra Oschman; Tara McCabe; Robert J Kuhn
Journal:  Am J Health Syst Pharm       Date:  2011-07-01       Impact factor: 2.637

Review 4.  Amphetamine toxicity: experience with 127 cases.

Authors:  R W Derlet; P Rice; B Z Horowitz; R V Lord
Journal:  J Emerg Med       Date:  1989 Mar-Apr       Impact factor: 1.484

5.  Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

Authors:  J A Henry; K J Jeffreys; S Dawling
Journal:  Lancet       Date:  1992-08-15       Impact factor: 79.321

6.  The use of dexmedetomidine to facilitate opioid and benzodiazepine detoxification in an infant.

Authors:  Julia C Finkel; Ahmed Elrefai
Journal:  Anesth Analg       Date:  2004-06       Impact factor: 5.108

7.  Dexmedetomidine to treat lisdexamfetamine overdose and serotonin toxidrome in a 6-year-old girl.

Authors:  Olugbenga A Akingbola; Dinesh Singh
Journal:  Am J Crit Care       Date:  2012-11       Impact factor: 2.228

8.  Dexmedetomidine in a child with methylphenidate intoxication.

Authors:  Dayanand N Bagdure; Girija R Bhoite; Pamela D Reiter; Emily L Dobyns
Journal:  Indian J Pediatr       Date:  2012-05-05       Impact factor: 1.967

9.  A cannabinoid-intoxicated child treated with dexmedetomidine: a case report.

Authors:  Flora Cipriani; Aldo Mancino; Silvia Maria Pulitanò; Marco Piastra; Giorgio Conti
Journal:  J Med Case Rep       Date:  2015-07-03

10.  A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity.

Authors:  Murat Seyit; Bulent Erdur; Selim Kortunay; Aykut Yuksel; Atakan Yilmaz; Mert Ozen; Aykut Uyanik; Onder Tomruk; Ahmet Ergin
Journal:  Iran Red Crescent Med J       Date:  2015-06-01       Impact factor: 0.611

View more
  1 in total

1.  The Role of Dexmedetomidine in Pediatric Patients Presenting with an Anticholinergic Toxidrome.

Authors:  Mitchell Zekhtser; Erin Carroll; Molly Boyd; Shashikanth Ambati
Journal:  Case Rep Crit Care       Date:  2021-08-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.